CDK6 and urinary bladder carcinoma: Recently, it’s reported that miR-19a could act as an oncogenic microRNA in bladder cancer by targeting PTEN when miR-320c could inhibit tumorous behaviors of bladder cancer by targeting CDK6 and both of them could be potential biomarkers of bladder cancer [16,17].